2D'Amato ,Loughnan MS ,Flynn E,et al. Thalidomide is an inhibitor of angiogenesis. Proc Nalt Acad Sci USA,1994,91:4082-4085.
3O'keilly MS,Boem J,Shing Y,et al. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth. Cell,1997,88: 277-283.
4Ryan DP,Penson RT,Ahmed S,et al. Reality testing in cancer treatment: the phase trail of endostatin. The Oncologist,1999,4:501-508.
5Kisker O,Becker CM,Prox D,et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res,2001,61:7669-7674.
5Cursiefen C,Küchle M,Naumann GO. Angiogenesis in corneal diseases:histopathologic evaluation of 254 human corneal buttons with neovascularization[J].Cornea,1998,(06):611-613.doi:10.1097/00003226-199811000-00008.
6Philipp W,Speicher L,Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas[J].Investigative Ophthalmology & Visual Science,2000,(09):2514-2522.
7Ambati BK,Nozaki M,Singh N. Corneal avascularity is due to soluble VEGF receptor-1[J].Nature,2006,(7114):993-997.
8Kwak N,Okamoto N,Wood JM. VEGF is major stimulator in model of choroidal neovascularization[J].Investigative Ophthalmology & Visual Science,2000,(10):3158-3164.
9Pierce EA,Avery RL,Foley ED. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization[J].Proceedings of the National Academy of Sciences(USA),1995,(03):905-909.
10Adamis AP,Shima DT,Tolentino MJ. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate[J].Archives of Ophthalmology,1996,(01):66-71.doi:10.1001/archopht.1996.01100130062010.
